Variant report
Variant | rs11633242 |
---|---|
Chromosome Location | chr15:78667720-78667721 |
allele | A/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:78664800-78668000 | Enhancers | Liver | Liver |
2 | chr15:78664800-78668200 | Enhancers | Fetal Intestine Small | intestine |
3 | chr15:78665000-78668200 | Enhancers | Fetal Intestine Large | intestine |
4 | chr15:78665400-78673600 | Weak transcription | H1 Cell Line | embryonic stem cell |
5 | chr15:78665400-78673600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
6 | chr15:78665400-78681400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr15:78666400-78667800 | Enhancers | Gastric | stomach |
8 | chr15:78666400-78668000 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr15:78666400-78668000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
10 | chr15:78666600-78667800 | Enhancers | Pancreas | Pancrea |
11 | chr15:78666600-78668200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr15:78666600-78668200 | Enhancers | Sigmoid Colon | Sigmoid Colon |
13 | chr15:78666800-78667800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
14 | chr15:78666800-78667800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
15 | chr15:78666800-78668000 | Flanking Active TSS | HepG2 | liver |
16 | chr15:78666800-78668000 | Enhancers | HMEC | breast |
17 | chr15:78666800-78668000 | Enhancers | NHEK | skin |
18 | chr15:78666800-78668200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
19 | chr15:78667000-78667800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
20 | chr15:78667000-78667800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
21 | chr15:78667000-78667800 | Flanking Active TSS | A549 | lung |
22 | chr15:78667000-78668000 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
23 | chr15:78667000-78668000 | Flanking Active TSS | Hela-S3 | cervix |
24 | chr15:78667000-78668200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
25 | chr15:78667000-78668200 | Enhancers | Placenta | Placenta |
26 | chr15:78667000-78668200 | Enhancers | Placenta Amnion | Placenta Amnion |
27 | chr15:78667200-78667800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
28 | chr15:78667200-78667800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
29 | chr15:78667200-78667800 | Active TSS | Rectal Mucosa Donor 29 | rectum |
30 | chr15:78667400-78667800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
31 | chr15:78667400-78667800 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
32 | chr15:78667600-78667800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
33 | chr15:78667600-78667800 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
34 | chr15:78667600-78667800 | Enhancers | Duodenum Mucosa | Duodenum |
35 | chr15:78667600-78667800 | Flanking Active TSS | Stomach Mucosa | stomach |
36 | chr15:78667600-78704400 | Weak transcription | Lung | lung |